{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:32:47Z","timestamp":1793205167421,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"vor","delay-in-days":2100,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1111\/j.1469-0691.2009.02738.x","type":"journal-article","created":{"date-parts":[[2009,3,20]],"date-time":"2009-03-20T17:46:57Z","timestamp":1237571217000},"page":"212-217","source":"Crossref","is-referenced-by-count":87,"title":["Clinical impact of antibiotic-resistant Gram-positive pathogens"],"prefix":"10.1016","volume":"15","author":[{"given":"H.M.","family":"Lode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2009.02738.x_bib1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1469-0691.2008.02067.x","article-title":"All EU hands to the EU pumps: the Science Academies of Europe (EASAC) recommend strong support of research to tackle antibacterial resistance","volume":"14","author":"Gyssens","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ES\u041aA\u0420\u0415! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib3","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1086\/499404","article-title":"Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment","volume":"42","author":"McDonald","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib4","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.1086\/533592","article-title":"Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains","volume":"46","author":"Sakoulas","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1086\/527392","article-title":"Vancomycin-resistant Staphylococcus aureus in the United States, 2002\u20132006","volume":"46","author":"Sievert","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib6","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/499406","article-title":"The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs","volume":"42","author":"Cosgrove","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib7","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3201\/eid1006.020665","article-title":"Reference group choice and antibiotic resistance outcomes","volume":"10","author":"Kaye","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib8","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/375081","article-title":"The impact of antimicrobial resistance on health and economic outcomes","volume":"36","author":"Cosgrove","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib9","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0140-6736(03)15021-0","article-title":"Community-acquired pneumonia","volume":"362","author":"File","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1086\/500142","article-title":"The clinical relevance of penicillin-resistant Streptococcus pneumoniae: a new perspective","volume":"42","author":"File","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJM199508243330802","article-title":"Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain","volume":"333","author":"Pallares","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.idc.2004.07.003","article-title":"Antibacterial drug resistance: implications for the treatment of patients with community-acquired pneumonia","volume":"18","author":"Metlay","year":"2004","journal-title":"Infect Dis Clin North Am"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib13","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1086\/322623","article-title":"Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance","volume":"33","author":"Moroney","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/377534","article-title":"An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome","volume":"37","author":"Yu","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib15","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1086\/500140","article-title":"The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis","volume":"42","author":"Tleyjeh","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1086\/381886","article-title":"Drug-resistant pneumococcal pneumonia: clinical relevance and related factors","volume":"38","author":"Aspa","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib17","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.rmed.2007.04.008","article-title":"Managing community-acquired pneumonia: a European perspective","volume":"101","author":"Lode","year":"2007","journal-title":"Respir Med"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib18","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1086\/315761","article-title":"Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries","volume":"182","author":"Henriques","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM200202213460820","article-title":"Emergence of macrolide resistance during treatment of pneumococcal pneumonia","volume":"346","author":"Musher","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib20","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/318157","article-title":"Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin","volume":"31","author":"Kelley","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/341978","article-title":"Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae","volume":"35","author":"Lonks","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib22","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/jac\/dkg116","article-title":"Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral beta-lactams","volume":"51","author":"Van Kerkhoven","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib23","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1086\/505871","article-title":"Macrolide resistance in bacteremic pneumococcal disease: implications for patient management","volume":"43","author":"Daneman","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib24","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1086\/497594","article-title":"Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter?","volume":"42","author":"Peterson","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib26","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(63)91687-8","article-title":"Methicillin resistance in staphylococci","volume":"1","author":"Jevons","year":"1963","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib27","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0140-6736(06)68853-3","article-title":"Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a publichealth threat","volume":"368","author":"Grundmann","year":"2006","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib28","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1086\/587893","article-title":"A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004\u20132005","volume":"46","author":"Liu","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/345476","article-title":"Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis","volume":"36","author":"Cosgrove","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1086\/502522","article-title":"The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges","volume":"26","author":"Cosgrove","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1086\/502523","article-title":"Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia","volume":"26","author":"Reed","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib32","first-page":"36","article-title":"Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection","volume":"1","author":"Engemann","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1086\/589717","article-title":"Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000\u20132006","volume":"198","author":"Laupland","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(88)91037-9","article-title":"Vancomycin-resistant enterococci","volume":"1","author":"Uttley","year":"1988","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib35","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/clinids\/23.6.1234","article-title":"Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality","volume":"23","author":"Edmond","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0732-8893(99)00136-4","article-title":"A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia","volume":"36","author":"Bhavnani","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib37","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/archinte.162.19.2223","article-title":"Health and economic outcomes of vancomycin-resistant enterococci","volume":"162","author":"Carmeli","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/430909","article-title":"Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis","volume":"41","author":"DiazGranados","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib47","first-page":"124","article-title":"Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis","volume":"41","author":"Chou","year":"2008","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib48","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.molmed.2007.04.004","article-title":"New strategies for combating multidrug-resistant bacteria","volume":"13","author":"Wright","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib49","series-title":"Tackling antibacterial resistance in Europe. AESAC policy report","author":"European Academies Science Advisory Council","year":"2007"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib39","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1086\/427512","article-title":"Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection","volume":"191","author":"DiazGranados","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib40","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1086\/313694","article-title":"Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia","volume":"30","author":"Garbutt","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib41","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/501624","article-title":"Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality","volume":"20","author":"Lautenbach","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib42","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/clinids\/22.4.663","article-title":"Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium","volume":"22","author":"Linden","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib43","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1086\/339211","article-title":"Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center","volume":"34","author":"Lodise","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib44","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/520311","article-title":"Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes","volume":"26","author":"Lucas","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib45","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/infdis\/172.4.993","article-title":"Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections","volume":"172","author":"Shay","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02738.x_bib46","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-135-7-200110020-00007","article-title":"Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study","volume":"135","author":"Vergis","year":"2001","journal-title":"Ann Intern Med"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14621388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14621388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T00:36:26Z","timestamp":1558226186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14621388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1198743X14621388"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2009.02738.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}